| Name | Title | Contact Details |
|---|
Confluence Health is an integrated, rural healthcare delivery system with two hospitals, multi-specialty care in more than 30 service lines and primary care in 12 communities across North Central Washington. Our 250+ physicians and 150+ advanced practice clinicians serve an area of approximately 12,000 square miles and cover nearly every corner of the region through specialty outreach. Confluence Health is dedicated to improving our patients` health by providing safe, high-quality care in a compassionate and cost-effective manner. Core Values • Our patients are the reason for our being, and their needs will drive all of our actions. • We will treat everyone with dignity,respect and compassion. • We will continue to innovate ways to improve the delivery of excellent, high value care. • We will measure successes and failures, and use the results to drive further improvement. • We will be a good neighbor in the communities we serve with donations of time, talent, and capital. • We will be ethical and accountable in all of our decisions and actions.
Pediatric Services of America, Inc (PSA Healthcare) is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Pediatric Services of America, Inc (PSA Healthcare) is based in Norcross, GA. You can find more information on Pediatric Services of America, Inc (PSA Healthcare) at www.psahealthcare.com
Hemosphere is a Eden Prairie, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.
Kryo, Inc. is the world`s leading innovator of temperature-regulated and climate-control sleep solutions engineered to optimize health and wellness through enhanced quality sleep and patented technology. Kryo ranks no. 615 on the 2020 Inc. 5000 list.